Novel Tumour Endothelial Markers

Development Stage: 1 - Target Validation

Description

Target Validation

Genes specifically expressed in tumour endothelial cells have been identified using an in silico approach. On-going expression and functional analysis indicates that they are potentially good antibody and/or small molecule targets for development of anti-angiogenic/vascular targeting therapeutics.


For more information please contact

Dr Raj Mehta

+44 (0) 20 3469 6300 .(JavaScript must be enabled to view this email address)